RxDoctor Payments Data

Holly Gaede, NP

Nurse Practitioner · Waterloo, IANPI 1144416488

Payments from drug & device makers

$2,592in general payments, 2019–2025

Across 59 payments — averaging $43.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Astellas Pharma US Inc$262
  • Laborie Medical Technologies Corp.$89
  • Boston Scientific$81
  • AbbVie$76
  • Medtronic$74
  • plus $203 from 4 others

What the payments were for

  • Travel & lodging$1,13344%
  • Food & beverage$1,29550%
  • Education$1646%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,592 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Medicare billing

Part B allowed, 2024
$127,034
Medicare patients
591
Services billed
2,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron489$278,784
XtandiEnzalutamide11$144,729
GemtesaVibegron94$49,772
Tamsulosin Hcl883$19,740
Methenamine Hippurate219$12,685
Finasteride691$10,558
Fesoterodine Fumarate ErFesoterodine Fumarate37$9,467
Fosfomycin Tromethamine37$8,712
PremarinEstrogens, Conjugated16$7,120
Oxybutynin Chloride ErOxybutynin Chloride281$5,953
Estradiol69$5,894
Trospium Chloride ErTrospium Chloride32$5,870
Solifenacin Succinate153$5,239
Potassium Citrate ErPotassium Citrate42$4,009
Silodosin53$3,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq, Xtandi$262$423,513500 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

Other nurse practitioner in Waterloo

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →